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Introduction
Cytochrome P450 2D6 (CYP2D6) is a clinically impor-
tant CYP, metabolising approximately 25% common
drugs. We investigated the clinical effect of acute kidney
injury (AKI) on hepatic CYP2D6 metabolism in critically
ill adults, using the probe drug tramadol (abstract 470).
We found no effect of AKI but a strong CYP2D6 geno-
type/phenotype influence on tramadol metabolism.
Rodent studies indicate no change or impaired
CYP2D6 metabolism in chronic kidney disease and AKI
(Refs [1-3]). No published human or animal data has
examined CYP2D6 transcription, translation or activity
in AKI. Previously we demonstrated no change in
CYP2D6 transcription when pooled serum from patients
with end-stage kidney disease (ESKD) was applied to
human HepG2 cells, known to express the functional
CYP2D6*1 allele.
Objectives
We aimed to determine whether a transcriptional
change occurred in CYP2D6 expression when hepato-
cytes are exposed to serum from critically ill patients
with and without AKI.
Methods
As part of a clinical study of hepatic drug metabolism in
AKI, serum from critically ill adult patients was stored
at -80ºC. Serum from 16 patients with the severest AKI
(KDIGO 3, not yet on renal replacement, highest fold-
change in serum creatinine) was compared to that of 15
critically ill controls without AKI. HepG2 cells (human
hepatoma cell line) were exposed to medium with 10%
individual human serum in separate wells for 24 h, then
lysed. CYP2D6 gene expression was examined by real
time reverse transcriptase quantitative PCR (q-rt-RT-
PCR). Statistical analysis was performed using Biorad
CFX 3.1 Software.
Results
The patient demographics are shown.
Cells displayed no obvious morphological differences.
An increase in relative CYP2D6 transcription occurred
(1.14 vs 1.00, p = 0.037) when cells were exposed to
serum from individual patients with AKI compared to
those without.
Conclusions
In contrast to the clinical study finding that CYP2D6
metabolism is not altered by AKI, a significant change in
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Figure 1 CYP2D6 expression could not be evaluated by
Western blotting, due to low expression of CYP2D6 in the cells
(< 2% all CYP).
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increase mRNA transcription occurred when sera were
individually tested. The functionality of this transcript is
uncertain and whether it translates into increased cellular
CYP2D6 protein concentration in AKI remains unknown.
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Table 1. Patient Demographics for Critically Ill
Value - Median [range] Critically Ill, no AKI (n=15) (KDIGO 0) Critically Ill, Severe AKI (n=16) (KDIGO 3)
Age (y) 77 (22-88) 58.5 (19-73)
Sex F:M 7:8 4:12
APACHE II score 20 (5-25) 25 (13-27)
SOFA score 7 (1-11) 7 (3-14)
Baseline Serum Creatinine (umol/L) 85 (58-112) 73 (46-114)
Fold change in Serum Creat from Baseline on study day 0.97 (0.5-1.16) 3.87 (3.1-10.1)
Serum Creatinine when studied (umol/L) 79 (41-131) 304 (157-595)
Cellular Confluence at Harvest (%) 86 (80-90) 85 (80-90)
[Tramadol] ((T4-T0) (ng/mL) [All genotypes included] 23.5 (14.3-39.8) 30.0 (11.7-41.4)
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